Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00085
|
|||||
Drug Name |
Pentamidine
|
|||||
Synonyms |
1,3-BIS(4-AMIDINOPHENOXY)PENTANE; 4, 4'-Diamidinodiphenoxypentane; 4,4'-(1,5-Pentanediylbis(oxy))bis-benzenecarboximidamide; 4,4'-(Pentamethylenedioxy)dibenzamide; 4,4'-(Pentamethylenedioxy)dibenzamidine; 4,4'-Diamidino-.alpha.,.omega.-diphenoxypentane; 4,4'-Diamidinodiphenoxypentane; 4,4'-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide; 4-[5-(4-Carbamimidoylphenoxy)pentoxy]benzenecarboximidamide; Benzenecarboximidamide, 4,4'-(1,5-pentanediylbis(oxy))bis-(9CI); Lomidine; Lomidine (TN); MB 800; MB-800; Nebupent; Nebupent (*Isethionate); Nebupent (as isethionate); P,p'-(Pentamethylene-dioxy)bis-benzamidine; P,p'-(Pentamethylenedioxy)bis[benzamidine]; P,p'-(Pentamethylenedioxy)dibenzamidine; PENTAM; PENTAMIDINE ISETHIONATE; PNT; Pentacarinat; Pentacarinat (as isethionate); Pentam 300; Pentam 300 (*Isethionate); Pentam 300 (as isethionate); Pentamide; Pentamidin; Pentamidina; Pentamidina [DCIT]; Pentamidine (INN); Pentamidine Isethionate 2-Hydroxy-Ethanesulfonic Acid;Pentamidine [INN:BAN:DCF]; Pentamidine isetionate; Pentamidine mesylate; Pentamidinum; Pentamidinum [INN-Latin]; Pneumopent; RP 2512 (*Isethionate); RP-2512
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Human immunodeficiency virus infection [ICD11: 1C62.Z] | Approved | [1] | |||
Therapeutic Class |
Antifungal Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C19H24N4O2
|
|||||
Canonical SMILES |
C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N
|
|||||
InChI |
InChI=1S/C19H24N4O2/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23)
|
|||||
InChIKey |
XDRYMKDFEDOLFX-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 100-33-4
|
|||||
Pharmaceutical Properties | Molecular Weight | 340.4 | Topological Polar Surface Area | 118 | ||
Heavy Atom Count | 25 | Rotatable Bond Count | 10 | |||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
2.6
|
|||||
PubChem CID | ||||||
PubChem SID |
103167313
, 103927078
, 104307277
, 11371352
, 11374018
, 11446573
, 11467701
, 11484026
, 11486282
, 11487971
, 11490092
, 11492195
, 117524407
, 14802371
, 24262996
, 26697116
, 26704279
, 29223821
, 46508562
, 47515246
, 47810678
, 47810679
, 47959662
, 48110386
, 48184930
, 48416390
, 49698900
, 49829609
, 49877520
, 50096576
, 50123735
, 50123736
, 53787921
, 57322420
, 596087
, 75273
, 7687717
, 78291630
, 7889974
, 7980274
, 81061089
, 8152906
, 85256751
, 85261596
, 88835490
, 90944750
, 92308870
, 92711694
, 96025020
, 9624
|
|||||
ChEBI ID |
ChEBI:45081
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | OCT-1 | Transporter Info | Km = 36.4 microM | Chinese hamster ovary (CHO) cells-OCT1 | [2] | |
References | ||||||
1 | Pentamidine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters. Drug Metab Dispos. 2009 Feb;37(2):424-30. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.